MYOK
MyoKardia, Inc. Common Stock
MYOK
MYOK
Delisted
MYOK was delisted on the 16th of November, 2020.
121 hedge funds and large institutions have $1.75B invested in MyoKardia, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 66 increasing their positions, 32 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
5% less funds holding
Funds holding: 128 → 121 (-7)
29% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 21
Holders
121
Holding in Top 10
10
Calls
$4.04M
Puts
$3.68M
Top Buyers
| 1 | +$43.2M | |
| 2 | +$40.8M | |
| 3 | +$29.9M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$29.5M |
| 5 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$23.8M |
Top Sellers
| 1 | -$43.2M | |
| 2 | -$33.2M | |
| 3 | -$6.11M | |
| 4 |
Axa
Paris,
France
|
-$5.03M |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
-$4.98M |